关键词云

成果统计

合作作者[TOP 5]

  • Zhang, Sulin

    合作成果数:5

  • 樊子生

    合作成果数:4

  • Cui, Rongrong

    合作成果数:3

  • 蒋华良

    合作成果数:2

  • 周敬怡

    合作成果数:2

郑明月 其他
所在学院: 物质科学与技术学院
职务: 临港实验室兼职导师
研究方向:
备注: --
郑明月

科研成果

6 1605 238 62 0 3
Items Views Downloads TC[WOS] TC[CSCD] H-index
排序方式:
 [1] Hou, Hui.,Zhou, Jingyi.,Sui, Qibang.,Zhang, Changfa.,Su, Zhaoming.,...&Zhang, Sulin.(2025).Discovery of 3‑(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity.JOURNAL OF MEDICINAL CHEMISTRY.浏览/下载:14/4; 被引[WOS]:0; IF:6.8/7.1评论推荐收藏
 [2] Ge, Zhiming.,Fan, Zisheng.,He, Wei.,Zhou, Guizhen.,Zhou, Yidi.,...&Zhang, Sulin.(2025).Recent advances in targeted degradation in the RAS pathway.FUTURE MEDICINAL CHEMISTRY,17(6).浏览/下载:49/3; 被引[WOS]:0; IF:3.2/3.7评论推荐收藏
 [3] Zhang, Yinghui.,Liu, Yadan.,Jiang, Bing.,Chen, Lifan.,Hu, Jie.,...&Zhang, Sulin.(2024).Targeting STING oligomerization with licochalcone D ameliorates STING-driven inflammatory diseases.SCIENCE CHINA-LIFE SCIENCES.浏览/下载:289/5; 被引[WOS]:3; IF:8.0/7.3评论推荐收藏
 [4] Zhou, Chuan.,Fan, Zisheng.,Gu, Yuejiao.,Ge, Zhiming.,Tao, Zhaofan.,...&Xu, Tianfeng.(2024).Design, Synthesis, and Biological Evaluation of Potent and Selective PROTAC Degraders of Oncogenic KRASG12D.JOURNAL OF MEDICINAL CHEMISTRY,67(2).浏览/下载:332/15; 被引[WOS]:11; IF:6.8/7.1评论推荐收藏
 [5] Chen, Lifan.,Fan, Zisheng.,Chang, Jie.,Yang, Ruirui.,Hou, Hui.,...&Zheng, Mingyue.(2023).Sequence-based drug design as a concept in computational drug design.NATURE COMMUNICATIONS,14(1).浏览/下载:579/207; 被引[WOS]:46; IF:14.7/16.1评论推荐收藏
 [6] Xu, Lan-song.,Zheng, Su-xin.,Mei, Liang-he.,Yang, Ke-xin.,Wang, Ya-fang.,...&Xie, Cheng-ying.(2023).143D, a novel selective KRASG12C inhibitor exhibits potent antitumor activity in preclinical models.ACTA PHARMACOLOGICA SINICA;.浏览/下载:342/4; 被引[WOS]:2; IF:6.9/7.6评论推荐收藏